Return to search

Heptares Gets Seeded

Heptares Therapeutics Ltd. has spun out of the MRC Laboratory of Molecular Biology in Cambridge, with an undisclosed amount of seed funding from MVM Life Science Partners. Heptares plans to apply structural knowledge of G-protein coupled receptors) to the design and development of its own drug molecules. www.mrc.ac.uk